Soleus Capital Management »

Cervomed shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Cervomed (CRVO) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Cervomed

Tip: Access up to 7 years of quarterly data

All positions including Cervomed held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cervomed by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.0M 127k 23.30

More positions owned by Soleus Capital Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
United Therapeutics Corporation (UTHR)
Edap Tms S A Sponsored Adr (EDAP)
Iovance Biotherapeutics (IOVA)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Tg Therapeutics (TGTX)
Celcuity (CELC)
Jasper Therapeutics Com New (JSPR)
Neuropace (NPCE)
Essa Pharma Com New (EPIX)
Organogenesis Hldgs (ORGO)
Axogen (AXGN)
Humana (HUM)
SurModics (SRDX)
Revolution Medicines (RVMD)

View all positions for Soleus Capital Management

Top funds holding Cervomed

RA Capital Management
Armistice Capital
Ikarian Capital
Adage Capital Partners GP
Soleus Capital Management
Crown Advisors Management
Boothbay Fund Management
CWM
Vanguard Group
BlackRock
Geode Capital Management
J. Goldman & Co
Point72 Asset Management
Hoey Investments
Cubist Systematic Strategies

View all funds holding Cervomed